FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792215135> ?p ?o ?g. }

• W2792215135 abstract "Three classes of anti-hyperglycaemic medications are distinguished by their urinary sodium excretion-enhancing and blood pressure-lowering actions: long-acting glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors. Yet, these drugs exert different effects on macrovascular risk. Glucagon-like peptide-1 receptor agonists reduce atherosclerotic thromboembolic events, but have little effect on heart failure; sodium-glucose co-transporter-2 inhibitors decrease the occurrence of heart failure, but have minimal effect on myocardial infarction and stroke; and dipeptidyl peptidase-4 inhibitors do not ameliorate either atherosclerotic thromboembolic events or heart failure. Similarly, the three classes of drugs differ in their early effects on renal function. Dipeptidyl peptidase-4 inhibitors produce a small decrease in renal function that persists for the duration of treatment, and they do not prevent serious adverse renal events. For glucagon-like peptide-1 receptor agonists, a small early decrease in renal function persists for 2 years and is superseded by a small improvement in renal function, with no effect on renal outcomes. In contrast, an initial decrease in glomerular filtration with sodium-glucose co-transporter-2 inhibitors persists for only 1 year and is superseded by a durable improvement in renal function and a reduced risk of serious adverse renal events. These differences may be related to different actions on the proximal tubular reabsorption of sodium, and thereby, on glomerular hyperfiltration. Anti-hyperglycaemic drugs that have natriuretic actions differ markedly in their ability to modulate macrovascular and microvascular risk. These contrasting profiles cannot be predicted by their effects on blood glucose or blood pressure." @default.
• W2792215135 created "2018-03-29" @default.
• W2792215135 creator A5042766753 @default.
• W2792215135 date "2018-04-11" @default.
• W2792215135 modified "2023-10-16" @default.
• W2792215135 title "Contrasting effects on the risk of macrovascular and microvascular events of antihyperglycemic drugs that enhance sodium excretion and lower blood pressure" @default.
• W2792215135 cites W1970306100 @default.
• W2792215135 cites W1974994009 @default.
• W2792215135 cites W1993252135 @default.
• W2792215135 cites W1996374895 @default.
• W2792215135 cites W2020778102 @default.
• W2792215135 cites W2027213678 @default.
• W2792215135 cites W2048763821 @default.
• W2792215135 cites W2064130493 @default.
• W2792215135 cites W2094758439 @default.
• W2792215135 cites W2100409734 @default.
• W2792215135 cites W2102186999 @default.
• W2792215135 cites W2108588975 @default.
• W2792215135 cites W2113094401 @default.
• W2792215135 cites W2118341353 @default.
• W2792215135 cites W2125399797 @default.
• W2792215135 cites W2128814368 @default.
• W2792215135 cites W2137121530 @default.
• W2792215135 cites W2142830692 @default.
• W2792215135 cites W2146264128 @default.
• W2792215135 cites W2151920020 @default.
• W2792215135 cites W2155156894 @default.
• W2792215135 cites W2156671722 @default.
• W2792215135 cites W2157945384 @default.
• W2792215135 cites W2214416180 @default.
• W2792215135 cites W2252435576 @default.
• W2792215135 cites W2337454357 @default.
• W2792215135 cites W2340643800 @default.
• W2792215135 cites W2424539745 @default.
• W2792215135 cites W2425644022 @default.
• W2792215135 cites W2505843168 @default.
• W2792215135 cites W2519510391 @default.
• W2792215135 cites W2534221266 @default.
• W2792215135 cites W2542456927 @default.
• W2792215135 cites W2583476095 @default.
• W2792215135 cites W2584401577 @default.
• W2792215135 cites W2594555601 @default.
• W2792215135 cites W2595010755 @default.
• W2792215135 cites W2604623769 @default.
• W2792215135 cites W2617258928 @default.
• W2792215135 cites W2626446274 @default.
• W2792215135 cites W2626992208 @default.
• W2792215135 cites W2639738157 @default.
• W2792215135 cites W2662343212 @default.
• W2792215135 cites W2741979119 @default.
• W2792215135 cites W2752707491 @default.
• W2792215135 cites W2754041380 @default.
• W2792215135 cites W2766105255 @default.
• W2792215135 cites W2766946706 @default.
• W2792215135 cites W3198570063 @default.
• W2792215135 doi "https://doi.org/10.1111/dme.13618" @default.
• W2792215135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29532519" @default.
• W2792215135 hasPublicationYear "2018" @default.
• W2792215135 type Work @default.
• W2792215135 sameAs 2792215135 @default.
• W2792215135 citedByCount "4" @default.
• W2792215135 countsByYear W27922151352019 @default.
• W2792215135 countsByYear W27922151352020 @default.
• W2792215135 crossrefType "journal-article" @default.
• W2792215135 hasAuthorship W2792215135A5042766753 @default.
• W2792215135 hasConcept C126322002 @default.
• W2792215135 hasConcept C127413603 @default.
• W2792215135 hasConcept C134018914 @default.
• W2792215135 hasConcept C156490143 @default.
• W2792215135 hasConcept C159641895 @default.
• W2792215135 hasConcept C2777180221 @default.
• W2792215135 hasConcept C2778198053 @default.
• W2792215135 hasConcept C2780645631 @default.
• W2792215135 hasConcept C500558357 @default.
• W2792215135 hasConcept C555293320 @default.
• W2792215135 hasConcept C71924100 @default.
• W2792215135 hasConcept C78519656 @default.
• W2792215135 hasConcept C84393581 @default.
• W2792215135 hasConcept C90466245 @default.
• W2792215135 hasConcept C98274493 @default.
• W2792215135 hasConceptScore W2792215135C126322002 @default.
• W2792215135 hasConceptScore W2792215135C127413603 @default.
• W2792215135 hasConceptScore W2792215135C134018914 @default.
• W2792215135 hasConceptScore W2792215135C156490143 @default.
• W2792215135 hasConceptScore W2792215135C159641895 @default.
• W2792215135 hasConceptScore W2792215135C2777180221 @default.
• W2792215135 hasConceptScore W2792215135C2778198053 @default.
• W2792215135 hasConceptScore W2792215135C2780645631 @default.
• W2792215135 hasConceptScore W2792215135C500558357 @default.
• W2792215135 hasConceptScore W2792215135C555293320 @default.
• W2792215135 hasConceptScore W2792215135C71924100 @default.
• W2792215135 hasConceptScore W2792215135C78519656 @default.
• W2792215135 hasConceptScore W2792215135C84393581 @default.
• W2792215135 hasConceptScore W2792215135C90466245 @default.
• W2792215135 hasConceptScore W2792215135C98274493 @default.
• W2792215135 hasLocation W27922151351 @default.
• W2792215135 hasLocation W27922151352 @default.
• W2792215135 hasOpenAccess W2792215135 @default.
• W2792215135 hasPrimaryLocation W27922151351 @default.
• W2792215135 hasRelatedWork W1966234050 @default.

• next